BRAIN Biotech AG ( ETR:BNN ) shareholders will doubtless be very grateful to see the share price up 80% in the ...

Bob Duggan’s success shows you don’t need a Ph.D., or even a college education, to make money in the complex world of biotech ...

By focusing on data quality, domain-specific knowledge, and the synergy between humans and machine learning, AI and biotech ...

A dark money anti-pharma bus —A rare disease treatment approval for Zevra —An FTC lawsuit against pharmacy benefit managers ...

As a new regime and phase begin for the market and economy, after the FED cut interest rates by a surprising 50bps last ...

Cerevance, a company focused on developing precision novel therapeutics for central nervous system (CNS) diseases, announced ...

Shares of Summit Therapeutics, whose cancer drug candidate turned heads after it outperformed a blockbuster drug from Merck, ...

IPOs at three biotechs last week tempted insiders to make huge share purchases. This spilled over into buying at a couple of ...

Andres Maldonado of H.C. Wainwright reiterated a Buy rating for Corbus with an $80 price target. Oppenheimer also maintained ...

IBBQ is a relatively new US biotech ETF that competes with established peers like IBB and XBI. Read why I don't recommend ...

Ginkgo Bioworks is pivoting: Once a synthetic biology darling, the flailing company has now turned to AI-driven protein ...

Study resultsMarinomed Biotech AG reports positive clinical results for unique Carragelose eye drops 24.09.2024 / 07:45 CET/CESTThe issuer is solely responsible for the content of this ...